***Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Compared to placebo, oral semaglutide was associated with an additional cost of $10,183.91, resulting in ICERs of $38,675.49/LY and $39,853.22/QALY, which exceeded our preset WTP threshold
Feringa H, Blaha M, Blankstein R, Rivera J, Budoff M, Shaw L, Raggi P, Berman D, Callister T, Agatston A, Blumenthal R, Krumholz H , Nasir K
So, is there a real link between Wegovy and heart palpitations